{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:57:37Z","timestamp":1740146257837,"version":"3.37.3"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T00:00:00Z","timestamp":1503619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012538","name":"The Swedish Cancer Foundation","doi-asserted-by":"crossref","award":["070623, CAN 2007\/1044, 11 0544, CAN 2011\/471"],"award-info":[{"award-number":["070623, CAN 2007\/1044, 11 0544, CAN 2011\/471"]}],"id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Karolinska Institutet Cancer Strategic Grants","award":["5888\/05-722"],"award-info":[{"award-number":["5888\/05-722"]}]},{"DOI":"10.13039\/501100001862","name":"The Swedish Research Council","doi-asserted-by":"crossref","award":["521-2008-2899"],"award-info":[{"award-number":["521-2008-2899"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"crossref","award":["20130097"],"award-info":[{"award-number":["20130097"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Region Orebro County","award":["OLL-526041"],"award-info":[{"award-number":["OLL-526041"]}]},{"name":"Region Orebro County","award":["OLL-526041"],"award-info":[{"award-number":["OLL-526041"]}]},{"name":"Lion's Cancer Research Foundation, Univeristy of Umea"},{"name":"The Gustaf V Jubilee Fund","award":["154022"],"award-info":[{"award-number":["154022"]}]},{"name":"Region Vastmanland - Uppsala University Centre for Clinical Research Hospital of Vastmanland Vasteras"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0183816","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T17:36:51Z","timestamp":1503682611000},"page":"e0183816","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma"],"prefix":"10.1371","volume":"12","author":[{"given":"Cecilia","family":"Ranhem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Lillsunde Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e5kan","family":"Hedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats G.","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Cathrin","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellinor","family":"\u00d6stensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Sorbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Hellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2120-7222","authenticated-orcid":true,"given":"Sonia","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,8,25]]},"reference":[{"issue":"Suppl 1","key":"ref1","first-page":"S29","article-title":"Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"U Beller","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/LGT.0b013e3182800ee2","article-title":"Vaginal cancer: the experience from 2 large academic centers during a 15-year period","volume":"17","author":"CC Gunderson","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1048-891x.2004.014310.x","article-title":"Primary carcinoma of the vagina: factors influencing the age at diagnosis. The Radiumhemmet series 1956\u201396","volume":"14","author":"K Hellman","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ygyno.2016.03.011","article-title":"Brachytherapy improves survival in primary vaginal cancer","volume":"141","author":"A Orton","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"Suppl 2","key":"ref5","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.ijgo.2015.06.003","article-title":"Cancer of the vagina","volume":"131","author":"NF Hacker","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3802\/jgo.2016.27.e17","article-title":"Definitive treatment of primary vaginal cancer with radiotherapy: multi-institutional retrospective study of the Korean Radiation Oncology Group (KROG 12\u201309)","volume":"27","author":"JH Chang","year":"2016","journal-title":"J Gynecol Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ygyno.2014.09.018","article-title":"Adoption and impact of concurrent chemoradiation therapy for vaginal cancer: a National Cancer Data Base (NCDB) study","volume":"135","author":"MS Rajagopalan","year":"2014","journal-title":"Gynecol Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ygyno.2011.12.449","article-title":"Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina","volume":"125","author":"I Alonso","year":"2012","journal-title":"Gynecol Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"H De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1365-2559.2010.03727.x","article-title":"Primary squamous cell carcinoma of the vagina: human papillomavirus detection, p16(INK4A) overexpression and clinicopathological correlations","volume":"57","author":"V Fuste","year":"2010","journal-title":"Histopathology"},{"issue":"Suppl 10","key":"ref11","doi-asserted-by":"crossref","first-page":"K17","DOI":"10.1016\/j.vaccine.2008.06.021","article-title":"Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions","volume":"26","author":"AR Giuliano","year":"2008","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ygyno.2013.02.004","article-title":"Prognostic impact of human papilloma virus (HPV) genotyping and HPV-16 subtyping in vaginal carcinoma","volume":"129","author":"GL Larsson","year":"2013","journal-title":"Gynecol Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/AOG.0b013e31819bd6e0","article-title":"Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors","volume":"113","author":"JS Smith","year":"2009","journal-title":"Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/bjc.2014.32","article-title":"Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina","volume":"110","author":"K Hellman","year":"2014","journal-title":"Br J Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/IGC.0b013e31821bc615","article-title":"The prognostic role of human papillomavirus in patients with vaginal cancer","volume":"21","author":"AH Brunner","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-4608(03)00245-0","article-title":"A recurrent gain of chromosome arm 3q in primary squamous carcinoma of the vagina","volume":"148","author":"JK Habermann","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/IGC.0b013e31827670c4","article-title":"Prognostic significance of cell cycle- and invasion-related molecular markers and genomic instability in primary carcinoma of the vagina","volume":"23","author":"K Hellman","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3109\/0284186X.2014.953258","article-title":"LRIG and cancer prognosis","volume":"53","author":"D Lindquist","year":"2014","journal-title":"Acta Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"R431","DOI":"10.1530\/ERC-14-0179","article-title":"The LRIG family: enigmatic regulators of growth factor receptor signaling","volume":"21","author":"C Simion","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1525-1438.2007.01021.x","article-title":"LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking","volume":"18","author":"AK Lindstrom","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3892\/ijo.2012.1702","article-title":"Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma","volume":"42","author":"S Muller","year":"2013","journal-title":"Int J Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e2081","DOI":"10.1097\/MD.0000000000002081","article-title":"Expression of LRIG1 is associated with good prognosis for human non-small cell lung cancer","volume":"94","author":"Y An","year":"2015","journal-title":"Medicine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3109\/0284186X.2015.1021427","article-title":"LRIG1 is a prognostic biomarker in non-small cell lung cancer","volume":"54","author":"S Kvarnbrink","year":"2015","journal-title":"Acta Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1158\/1541-7786.MCR-11-0227","article-title":"Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERalpha-positive breast cancer","volume":"9","author":"SR Krig","year":"2011","journal-title":"Mol Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1080\/15592294.2015.1085140","article-title":"Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer","volume":"10","author":"M Lando","year":"2015","journal-title":"Epigenetics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"21593","DOI":"10.1074\/jbc.M113.486050","article-title":"Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3)","volume":"288","author":"H Rafidi","year":"2013","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3109\/0284186X.2010.492789","article-title":"LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix","volume":"49","author":"H Hedman","year":"2010","journal-title":"Acta Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00401-006-0032-5","article-title":"Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors","volume":"111","author":"D Guo","year":"2006","journal-title":"Acta Neuropathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gene.2004.02.002","article-title":"Characterization and tissue-specific expression of human LRIG2","volume":"332","author":"C Holmlund","year":"2004","journal-title":"Gene"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/bjc.2014.87","article-title":"Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer","volume":"110","author":"D Lindquist","year":"2014","journal-title":"Br J Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00441-003-0697-1","article-title":"LRIG1 protein in human cells and tissues","volume":"312","author":"J Nilsson","year":"2003","journal-title":"Cell Tissue Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ygyno.2011.04.049","article-title":"Correlation between LRIG1 and LRIG2 expressions and expression of 11 tumor markers, with special reference to tumor suppressors, in CIN and normal cervical epithelium","volume":"122","author":"AK Lindstrom","year":"2011","journal-title":"Gynecol Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.4081\/ejh.2014.2227","article-title":"Immunohistochemical LRIG3 expression in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer: association with expression of tumor markers, hormones, high-risk HPV-infection, smoking and patient outcome","volume":"58","author":"AK Lindstrom","year":"2014","journal-title":"Eur J Histochem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00042728-200504000-00008","article-title":"LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohistochemical analysis for 38 cases","volume":"31","author":"A Tanemura","year":"2005","journal-title":"Dermatol Surg"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/0284186X.2011.562239","article-title":"Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity","volume":"51","author":"X Wu","year":"2012","journal-title":"Acta Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.yexcr.2010.11.005","article-title":"Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1","volume":"317","author":"W Yi","year":"2011","journal-title":"Exper Cell Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0183816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T08:40:48Z","timestamp":1602837648000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0183816"}},"subtitle":[],"editor":[{"given":"Maria Lina","family":"Tornesello","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,25]]},"references-count":36,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0183816","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,8,25]]}}}